Clinical performance of a chemiluminescence SARS-CoV-2 antibody assay in a cohort of healthcare workers, blood donors and COVID-19 patients

Author:

Rangel GiselleORCID,Lopez Daysa,Chavarría Athneris,Mudarra Laiss,Britton GabrielleORCID,Villarreal AlcibiadesORCID

Abstract

ABSTRACTIntroductionSerological detection of antibodies against SARS-CoV-2 has become an essential tool to test vaccine efficacy and epidemiological surveillance of COVID-19. There have been limited published studies documenting the performance of SARS-CoV-2 antibody assays within hispanic populations.Materials and methodsWe evaluated the diagnostic performance of a chemiluminescence enzyme immunoassay (CLIA) on a set of 1,035 samples including pre-pandemic samples, healthcare workers (HCW), blood donors (BD) and COVID-19 positive confirmed by RT-PCR collected from April to December 2020.ResultsThrough a ROC curve the CLIA test had a high diagnostic performance, with an AUC of 0.9854 (CI95%95.68-100), P <0.0001. The analysis yielded a cut-off point 0.1950, sensitivity of 98.4% (CI95%95 91.54-99.9), and specificity of 93.8% (CI95%79.8 - 98.9). The diagnostic performance was also evaluated comparing the results with those obtained using other diagnostic techniques. Substantial agreement with the lateral flow chromatography and RT-PCR tests was found, and a high level of agreement with ELISA, with %PPA of 91.3 (CI95%84.0-95.5), % NPA of 97.7 (CI95%96.3-98.6), % OPA of 97.7 (CI95%96.3-98.6) and Cohen’s kappa value of 90.4 (CI95%85.8-94.9). A logistic regression was used to determine which of the independent variables predicted reactivity to CLIA test. A higher age was associated with an odds ratio (OR) of 1.043 (CI95%1.022-1.065), while the presence of at least one chronic disease was associated with an OR of 5.649 (CI95%3.089-10.329) greater likelihood of reactivity.ConclusionsCLIA test exhibited excellent performance making it a suitable test for seroprevalence surveillance at the community level.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3